These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 36551306)

  • 1. Lipidomic Profile Analysis of Lung Tissues Revealed Lipointoxication in Pulmonary Veno-Occlusive Disease.
    Khoury S; Beauvais A; Colas J; Saint-Martin Willer A; Perros F; Humbert M; Vandebrouck C; Montani D; Ferreira T; Antigny F
    Biomolecules; 2022 Dec; 12(12):. PubMed ID: 36551306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary vascular remodeling patterns and expression of general control nonderepressible 2 (GCN2) in pulmonary veno-occlusive disease.
    Nossent EJ; Antigny F; Montani D; Bogaard HJ; Ghigna MR; Lambert M; Thomas de Montpréville V; Girerd B; Jaïs X; Savale L; Mercier O; Fadel E; Soubrier F; Sitbon O; Simonneau G; Vonk Noordegraaf A; Humbert M; Perros F; Dorfmüller P
    J Heart Lung Transplant; 2018 May; 37(5):647-655. PubMed ID: 29108819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unique wreath-like smooth muscle proliferation of the pulmonary vasculature in pulmonary veno-occlusive disease versus pulmonary arterial hypertension.
    Lai YJ; Chen PR; Huang YL; Hsu HH
    J Formos Med Assoc; 2020 Jan; 119(1 Pt 2):300-309. PubMed ID: 31202500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Human and Experimental Pulmonary Veno-Occlusive Disease.
    Manaud G; Nossent EJ; Lambert M; Ghigna MR; Boët A; Vinhas MC; Ranchoux B; Dumas SJ; Courboulin A; Girerd B; Soubrier F; Bignard J; Claude O; Lecerf F; Hautefort A; Florio M; Sun B; Nadaud S; Verleden SE; Remy S; Anegon I; Bogaard HJ; Mercier O; Fadel E; Simonneau G; Vonk Noordegraaf A; Grünberg K; Humbert M; Montani D; Dorfmüller P; Antigny F; Perros F
    Am J Respir Cell Mol Biol; 2020 Jul; 63(1):118-131. PubMed ID: 32209028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease: a population-based study.
    Montani D; Girerd B; Jaïs X; Levy M; Amar D; Savale L; Dorfmüller P; Seferian A; Lau EM; Eyries M; Le Pavec J; Parent F; Bonnet D; Soubrier F; Fadel E; Sitbon O; Simonneau G; Humbert M
    Lancet Respir Med; 2017 Feb; 5(2):125-134. PubMed ID: 28087362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and management of pulmonary veno-occlusive disease.
    Solinas S; Boucly A; Beurnier A; Kularatne M; Grynblat J; Eyries M; Dorfmüller P; Sitbon O; Humbert M; Montani D
    Expert Rev Respir Med; 2023; 17(8):635-649. PubMed ID: 37578057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case report: pulmonary veno-occlusive disease: a rare but fatal cause of pulmonary hypertension in a patient following allogeneic stem cell transplantation.
    Katrien M; Dieter S; Anke D; Amelie D; De Pauw M; Eric D
    Acta Clin Belg; 2022 Jun; 77(3):697-702. PubMed ID: 34191691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary veno-occlusive disease: illustrative cases and literature review.
    Lechartier B; Boucly A; Solinas S; Gopalan D; Dorfmüller P; Radonic T; Sitbon O; Montani D
    Eur Respir Rev; 2024 Jan; 33(171):. PubMed ID: 38232988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension.
    Eyries M; Montani D; Girerd B; Perret C; Leroy A; Lonjou C; Chelghoum N; Coulet F; Bonnet D; Dorfmüller P; Fadel E; Sitbon O; Simonneau G; Tregouët DA; Humbert M; Soubrier F
    Nat Genet; 2014 Jan; 46(1):65-9. PubMed ID: 24292273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Good response to pulmonary arterial hypertension-targeted therapy in 2 pulmonary veno-occlusive disease patients: A case report.
    Zhang L; Wang Y; Zhang R
    Medicine (Baltimore); 2021 Oct; 100(41):e27334. PubMed ID: 34731104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary veno-occlusive disease: pathogenesis, risk factors, clinical features and diagnostic algorithm - state of the art.
    Szturmowicz M; Kacprzak A; Szołkowska M; Burakowska B; Szczepulska E; Kuś J
    Adv Respir Med; 2018; 86(3):. PubMed ID: 29960280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GCN2 Regulates ATF3-p38 MAPK Signaling Transduction in Pulmonary Veno-Occlusive Disease.
    Chen Z; Zhang J; Wei D; Chen J; Yang J
    J Cardiovasc Pharmacol Ther; 2021 Nov; 26(6):677-689. PubMed ID: 33988041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occupational exposure to organic solvents: a risk factor for pulmonary veno-occlusive disease.
    Montani D; Lau EM; Descatha A; Jaïs X; Savale L; Andujar P; Bensefa-Colas L; Girerd B; Zendah I; Le Pavec J; Seferian A; Perros F; Dorfmüller P; Fadel E; Soubrier F; Sitbon O; Simonneau G; Humbert M
    Eur Respir J; 2015 Dec; 46(6):1721-31. PubMed ID: 26541523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics and survival of Chinese patients diagnosed with pulmonary arterial hypertension who carry BMPR2 or EIF2KAK4 variants.
    Zeng Q; Yang H; Liu B; Ma Y; Liu Z; Chen Q; Li W; Luo Q; Zhao Z; Zhou Z; Xiong C
    BMC Pulm Med; 2020 May; 20(1):150. PubMed ID: 32471403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic Characterization of
    Hadinnapola C; Bleda M; Haimel M; Screaton N; Swift A; Dorfmüller P; Preston SD; Southwood M; Hernandez-Sanchez J; Martin J; Treacy C; Yates K; Bogaard H; Church C; Coghlan G; Condliffe R; Corris PA; Gibbs S; Girerd B; Holden S; Humbert M; Kiely DG; Lawrie A; Machado R; MacKenzie Ross R; Moledina S; Montani D; Newnham M; Peacock A; Pepke-Zaba J; Rayner-Matthews P; Shamardina O; Soubrier F; Southgate L; Suntharalingam J; Toshner M; Trembath R; Vonk Noordegraaf A; Wilkins MR; Wort SJ; Wharton J; ; Gräf S; Morrell NW
    Circulation; 2017 Nov; 136(21):2022-2033. PubMed ID: 28972005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary capillary haemangiomatosis: a distinct entity?
    Weatherald J; Dorfmüller P; Perros F; Ghigna MR; Girerd B; Humbert M; Montani D
    Eur Respir Rev; 2020 Jun; 29(156):. PubMed ID: 32461209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary veno-occlusive disease.
    Montani D; Lau EM; Dorfmüller P; Girerd B; Jaïs X; Savale L; Perros F; Nossent E; Garcia G; Parent F; Fadel E; Soubrier F; Sitbon O; Simonneau G; Humbert M
    Eur Respir J; 2016 May; 47(5):1518-34. PubMed ID: 27009171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary Capillary Hemangiomatosis and Pulmonary Veno-occlusive Disease.
    Chaisson NF; Dodson MW; Elliott CG
    Clin Chest Med; 2016 Sep; 37(3):523-34. PubMed ID: 27514598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Good response to PAH-targeted drugs in a PVOD patient carrying Biallelic EIF2AK4 mutation.
    Liang L; Su H; Ma X; Zhang R
    Respir Res; 2018 Oct; 19(1):192. PubMed ID: 30285736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pulmonary veno-occlusive disease].
    Boucly A; Girerd B; Bourlier D; Nemlaghi S; Caliez J; Savale L; Jaïs X; Dorfmüller P; Simonneau G; Sitbon O; Humbert M; Montani D
    Rev Mal Respir; 2018 Feb; 35(2):160-170. PubMed ID: 29501213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.